benserazide hydrochloride

Poland

Drugs containing this active substance

  • MADOPAR 62.5 MG

    Madopar is used in the treatment of Parkinson's disease. Some of its formulations are also indicated for the symptomatic treatment of restless legs syndrome (RLS), including in patients suffering from this syndrome in connection with renal failure requiring dialysis therapy.

    Form: capsules

    Active substance Dosage
    levodopa 50 mg
    benserazide hydrochloride 12.5 mg

    ATC: N04BA02

    Manufacturer: Roche Pharma AG

  • Madopar is used in the treatment of Parkinson's disease and in the symptomatic treatment of restless legs syndrome (RLS), including in patients with renal failure requiring dialysis therapy.

    Form: capsules

    Active substance Dosage
    levodopa 100 mg
    benserazide hydrochloride 28.5 mg

    ATC: N04BA02

    Manufacturer: Roche Pharma AG